163 related articles for article (PubMed ID: 33111255)
1. Adherence to the Sociedad Española de Oncología Médica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study.
Henao F; Manzano A; Lopez Lopez R; Gobartt AL; de Las Peñas R
Adv Ther; 2021 Jan; 38(1):290-303. PubMed ID: 33111255
[TBL] [Abstract][Full Text] [Related]
2. [Consensus on hereditary cancer between the Spanish Oncology Society and the primary care societies].
Robles L; Balmaña J; Barrel I; Grandes S; Graña B; Guillén C; Marcos H; Ramírez D; Redondo E; Sánchez J
Semergen; 2013; 39(5):259-66. PubMed ID: 23834976
[TBL] [Abstract][Full Text] [Related]
3. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
Estilo A; McCormick L; Rahman M
Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
[TBL] [Abstract][Full Text] [Related]
4. Sexual health after breast cancer: Recommendations from the Spanish Menopause Society, Federación Española de Sociedades de Sexología, Sociedad Española de Médicos de Atención Primaria and Sociedad Española de Oncología Médica.
Mendoza N; Molero F; Criado F; Cornellana MJ; González E;
Maturitas; 2017 Nov; 105():126-131. PubMed ID: 28268037
[TBL] [Abstract][Full Text] [Related]
5. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E;
Med Clin (Barc); 2013 Dec; 141(11):507.e1-507.e10. PubMed ID: 24169317
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary consensus on cancer management during pregnancy.
Cubillo A; Morales S; Goñi E; Matute F; Muñoz JL; Pérez-Díaz D; de Santiago J; Rodríguez-Lescure Á
Clin Transl Oncol; 2021 Jun; 23(6):1054-1066. PubMed ID: 33191439
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
[TBL] [Abstract][Full Text] [Related]
8. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
[TBL] [Abstract][Full Text] [Related]
9. Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Pose-Reino A; Runkle de la Vega I; de Jong-Laird A; Kabra M; Lindner U
Adv Ther; 2021 Feb; 38(2):1055-1067. PubMed ID: 33306187
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
Ramamohan V; Mladsi D; Ronquest N; Kamat S; Boklage S
Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
[TBL] [Abstract][Full Text] [Related]
11. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
Petereit C; Zaba O; Teber I; Lüders H; Grohé C
BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478
[TBL] [Abstract][Full Text] [Related]
12. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.
Quintanar T; Font C; Gallardo E; Barba R; Obispo B; Díaz-Pedroche C
Clin Transl Oncol; 2021 Apr; 23(4):697-708. PubMed ID: 32885400
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
Kim Y; Lee N; Lee KE; Gwak HS
Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
[TBL] [Abstract][Full Text] [Related]
15. Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study.
Berardi R; Mastroianni C; Lo Russo G; Buosi R; Santini D; Montanino A; Carnaghi C; Tiseo M; Chiari R; Camerini A; Barni S; De Marino V; Ferrari D; Cristofano A; Doni L; Freddari F; Fumagalli D; Portalone L; Sarmiento R; Schinzari G; Sperandi F; Tucci M; Inno A; Ciuffreda L; Mariotti M; Mariani C; Caramanti M; Torniai M; Gallucci R; Bennati C; Bordi P; Buffoni L; Galeassi A; Ghidini M; Grossi E; Morabito A; Vincenzi B; Arvat E
Ther Adv Med Oncol; 2019; 11():1758835919877725. PubMed ID: 31632468
[TBL] [Abstract][Full Text] [Related]
16. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
Arima H; Goto K; Motozawa T; Mouri M; Watanabe R; Hirano T; Ishikawa SE
Endocr J; 2021 Jan; 68(1):17-29. PubMed ID: 32863282
[TBL] [Abstract][Full Text] [Related]
17. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
Guillot Morales M; Visa L; Brozos Vázquez E; Feliu Batlle J; Khosravi Shahi P; Laquente Sáez B; de San Vicente Hernández BL; Macarulla T; Gironés Sarrió R
Clin Transl Oncol; 2024 Jul; 26(7):1570-1583. PubMed ID: 38329611
[TBL] [Abstract][Full Text] [Related]
18. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of hepatocellular carcinoma. Update consensus document from the AEEH, SEOM, SERAM, SERVEI and SETH].
Forner A; Reig M; Varela M; Burrel M; Feliu J; Briceño J; Sastre J; Martí-Bonmati L; Llovet JM; Bilbao JI; Sangro B; Pardo F; Ayuso C; Bru C; Tabernero J; Bruix J
Med Clin (Barc); 2016 Jun; 146(11):511.e1-511.e22. PubMed ID: 26971984
[TBL] [Abstract][Full Text] [Related]
20. Practical issues for the management of hyponatremia in oncology.
Berardi R; Antonuzzo A; Blasi L; Buosi R; Lorusso V; Migliorino MR; Montesarchio V; Zilembo N; Sabbatini R; Peri A
Endocrine; 2018 Jul; 61(1):158-164. PubMed ID: 29417373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
